Earnings Call · Q1 FY2024·2024-05-08

Q1 24EPS +100.00%*·Rev n/aQ4 23EPS -8.00%·Rev n/aQ3 23EPS +14.55%·Rev n/aQ2 23EPS +3.70%·Rev n/a⚠ consensus missing

Arcus Biosciences, Inc. RCUS

Pia Eaves — Vice President of Investor Relations and Strategy

For ease of listening, we will be referring to abbreviations of our molecule names — Unknown

Terry Rosen — Chief Executive Officer

Jennifer Jarrett — Unknown

Robert Goeltz — Chief Financial Officer

+5.8%1d on move date+5.3% vs SPY3d+12.8%5d+15.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCUS calls or request research access.

More RCUS calls Browse calls Request research access